{"id":53526,"date":"2012-10-04T16:26:01","date_gmt":"2012-10-04T16:26:01","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/bwh-researchers-discover-genetic-risk-for-uterine-fibroids.php"},"modified":"2012-10-04T16:26:01","modified_gmt":"2012-10-04T16:26:01","slug":"bwh-researchers-discover-genetic-risk-for-uterine-fibroids","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-medicine\/bwh-researchers-discover-genetic-risk-for-uterine-fibroids.php","title":{"rendered":"BWH researchers discover genetic risk for uterine fibroids"},"content":{"rendered":"<p><p>Public  release date: 4-Oct-2012  [ |   E-mail   |  Share    ]  <\/p>\n<p>    Contact: Marjorie Montemayor-Quellenberg    <a href=\"mailto:mmontemayor-quellenberg@partners.org\">mmontemayor-quellenberg@partners.org<\/a>    617-534-2208    Brigham and Women's    Hospital<\/p>\n<p>    BOSTON, MAUterine fibroids are the most common type of pelvic    tumors in women and are the leading cause of hysterectomy in    the United States. Researchers from Brigham and Women's    Hospital (BWH) are the first to discover a genetic risk allele    (an alternative form of a gene) for uterine fibroids in white    women using an unbiased, genome-wide approach. This discovery    will pave the way for new screening strategies and treatments    for uterine fibroids.  <\/p>\n<p>    The study will be published online on October 4, 2012 in The    American Journal of Human Genetics.  <\/p>\n<p>    The research team, led by Cynthia Morton, PhD, BWH director of    the Center for Uterine Fibroids and senior study author,    analyzed genetic data from over 7,000 white women. The    researchers detected genetic variants that are significantly    associated with uterine fibroid status in a span of three genes    including FASN which encodes a protein called FAS (fatty acid    synthase).  <\/p>\n<p>    Moreover, additional studies revealed that FAS protein    expression was three times higher in uterine fibroid samples    compared to normal myometrial tissue (muscle tissue that forms    the uterine wall). Over-expression of FAS protein is found in    various types of tumors and is thought to be important for    tumor cell survival.  <\/p>\n<p>    \"Our discovery foretells a path to personalized medicine for    women who have a genetic basis for development of uterine    fibroids,\" said Morton. \"Identification of genetic risk factors    may provide valuable insight into medical management.\"  <\/p>\n<p>    Study samples used were from various cohort studies, such as    the Finding Genes for Fibroids study and the Women's Genome    Health Study at BWH.  <\/p>\n<p>    Uterine fibroids may lead to abnormal vaginal bleeding,    infertility, pelvic pain and pregnancy complications. Uterine    fibroids are found in more than 75 percent of women of    reproductive age.  <\/p>\n<p>    ###  <\/p>\n<\/p>\n<p>The rest is here:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.eurekalert.org\/pub_releases\/2012-10\/bawh-brd100212.php\" title=\"BWH researchers discover genetic risk for uterine fibroids\">BWH researchers discover genetic risk for uterine fibroids<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Public release date: 4-Oct-2012 [ | E-mail | Share ] Contact: Marjorie Montemayor-Quellenberg <a href=\"mailto:mmontemayor-quellenberg@partners.org\">mmontemayor-quellenberg@partners.org<\/a> 617-534-2208 Brigham and Women's Hospital BOSTON, MAUterine fibroids are the most common type of pelvic tumors in women and are the leading cause of hysterectomy in the United States. Researchers from Brigham and Women's Hospital (BWH) are the first to discover a genetic risk allele (an alternative form of a gene) for uterine fibroids in white women using an unbiased, genome-wide approach <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-medicine\/bwh-researchers-discover-genetic-risk-for-uterine-fibroids.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[5],"tags":[],"class_list":["post-53526","post","type-post","status-publish","format-standard","hentry","category-genetic-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/53526"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=53526"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/53526\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=53526"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=53526"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=53526"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}